UPDF AI

Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.

A. Ananthakrishnan,Chengwei Luo,5 Autores,R. Xavier

2017 · DOI: 10.1016/j.chom.2017.04.010
Cell Host and Microbe · 384 Citações

TLDR

It is hypothesized that the trajectory of early microbiome changes may be a marker of response to IBD treatment, and a neural network algorithm, vedoNet, incorporating microbiome and clinical data, provided highest classifying power for clinical remission.